Atomo secures AUD4.5m from Global Health Investment Fund and former Macquarie CEO Allan Moss
Medical device specialist Atomo Diagnostics has raised AUD4.5 million in new equity funding from a number of professional investors including the New York-based Global Health Investment Fund (GHIF), as well as a company associated with former managing director and CEO of Macquarie Group, Allan Moss. The new investment follows receipt